EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Accelerating antimicrobial peptide design: Leveraging deep learning for rapid discovery

Ahmad M Al-Omari, Yazan H Akkam, Ala'a Zyout, Shayma'a Younis, Shefa M Tawalbeh, Khaled Al-Sawalmeh, Amjed Al Fahoum iD, Jonathan Arnold

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0315477 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Ahmad M Al-Omari und 7 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Systems and Informatics Engineering Department, College of Engineering, Yarmouk University, Irbid, Jordan. Hauptthemen laut MEDLINE: Deep Learning, Antimicrobial Peptides, Escherichia coli, Microbial Sensitivity Tests. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yarmouk University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial peptides (AMPs) are excellent at fighting many different infections. This demonstrates how important it is to make new AMPs that are even better at eliminating infections. The fundamental transformation in a variety of scientific disciplines, which led to the emergence of machine learning techniques, has presented significant opportunities for the development of antimicrobial peptides. Machine learning and deep learning are used to predict antimicrobial peptide efficacy in the study. The main purpose is to overcome traditional experimental method constraints. Gram-negative bacterium Escherichia coli is the model organism in this study. The investigation assesses 1,360 peptide sequences that exhibit anti- E . coli activity. These peptides’ minimal inhibitory concentrations have been observed to be correlated with a set of 34 physicochemical characteristics. Two distinct methodologies are implemented. The initial method involves utilizing the pre-computed physicochemical attributes of peptides as the fundamental input data for a machine-learning classification approach. In the second method, these fundamental peptide features are converted into signal images, which are then transmitted to a deep learning neural network. The first and second methods have accuracy of 74% and 92.9%, respectively. The proposed methods were developed to target a single microorganism (gram negative E . coli ), however, they offered a framework that could potentially be adapted for other types of antimicrobial, antiviral, and anticancer peptides with further validation. Furthermore, they have the potential to result in significant time and cost reductions, as well as the development of innovative AMP-based treatments. This research contributes to the advancement of deep learning-based AMP drug discovery methodologies by generating potent peptides for drug development and application. This discovery has significant implications for the processing of biological data and the computation of pharmacology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deep LearningAntimicrobial PeptidesEscherichia coliMicrobial Sensitivity TestsDrug DiscoveryDrug DesignMachine LearningNeural Networks, ComputerAntimicrobial Cationic PeptidesAnti-Bacterial AgentsHumans

Substanzen

Antimicrobial PeptidesAntimicrobial Cationic PeptidesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Biomedical Systems and Informatics Engineering Department, College of Engineering, Yarmouk University, Irbid, Jordan.
  • Medicinal Chemistry and Pharmacognosy Department, Faculty of Pharmacy, Yarmouk University, Irbid, Jordan.
  • Department of Basic Pathological Sciences, College of Medicine, Yarmouk University, Irbid, Jordan.
  • Genetics Department, University of Georgia, Athens, GA, United States of America.

ORCID-Profile: Amjed Al Fahoum

Förderung

  • Yarmouk University

Zitieren

APA

Al-Omari, A. M., Akkam, Y. H., Zyout, A., Younis, S., Tawalbeh, S. M., Al-Sawalmeh, K., Al Fahoum, A., & Arnold, J. (2024). Accelerating antimicrobial peptide design: Leveraging deep learning for rapid discovery. PLOS ONE. https://doi.org/10.1371/journal.pone.0315477

Vancouver

Al-Omari AM, Akkam YH, Zyout A, Younis S, Tawalbeh SM, Al-Sawalmeh K, et al. Accelerating antimicrobial peptide design: Leveraging deep learning for rapid discovery. PLOS ONE. 2024. doi:10.1371/journal.pone.0315477

BibTeX
@article{AlOmari2024,
  author = {Al-Omari, Ahmad M and Akkam, Yazan H and Zyout, Ala'a and Younis, Shayma'a and Tawalbeh, Shefa M and Al-Sawalmeh, Khaled and Al Fahoum, Amjed and Arnold, Jonathan},
  title = {Accelerating antimicrobial peptide design: Leveraging deep learning for rapid discovery},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0315477}
}
Kostenlos starten →